Journal of Clinical and Cellular Immunology : Citations & Metrics Report
Articles published in Journal of Clinical and Cellular Immunology have been cited by esteemed scholars and scientists all around the world. Journal of Clinical and Cellular Immunology has got h-index 42, which means every article in Journal of Clinical and Cellular Immunology has got 42 average citations.
Following are the list of articles that have cited the articles published in Journal of Clinical and Cellular Immunology.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
30 | 31 | 30 | 59 | 28 | 11 | 35 | 56 | 95 | 105 | 101 | 105 | 64 | 15 | 3 |
Research, Review articles and Editorials |
2 | 13 | 8 | 23 | 18 | 8 | 25 | 35 | 54 | 86 | 79 | 35 | 23 | 14 | 3 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
20 | 18 | 22 | 22 | 10 | 3 | 10 | 21 | 39 | 6 | 9 | 7 | 1 | 1 | 0 |
Conference proceedings |
0 | 16 | 15 | 6 | 0 | 98 | 178 | 206 | 171 | 160 | 195 | 156 | 74 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
653 | 826 | 931 | 1079 | 1018 | 971 | 871 | 851 | 753 | 550 | 276 | 145 | 43 | 40 | 0 |
| Journal total citations count | 8361 |
| Journal impact factor | 24.12 |
| Journal 5 years impact factor | 31.14 |
| Journal cite score | 30.45 |
| Journal h-index | 42 |
| Journal h-index since 2019 | 32 |
Important citations (1511)
Natarajan s (2014) diagnostic enigmas of retinopathy: new dimensions. indian journal of ophthalmology 62: 669. |
|
Zhou m, wang j, wang w, huang w, ding x, et al. (2016) placenta growth factor in eyes with neovascular glaucoma is decreased after intravitreal ranibizumab injection. plos one 11: e0146993. |
|
Siregar sa, elvioza e, victor aa, djatikusumo a, andayani ga, et al. (2016) comparison between intravitreal bevacizumab and triamcinolone acetonide in management of diabetic macular edema. ophthalmologica indonesiana 42. |
|
Bolinger mt, antonetti da (2016) moving past anti-vegf: novel therapies for treating diabetic retinopathy. international journal of molecular sciences 17: 1498. |
|
Callanan dg, loewenstein a, patel ss, massin p, corcóstegui b, et al. (2016) a multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema. graefe's archive for clinical and experimental ophthalmology 1-1. |
|
Afraei s, azizi g, zargar sj, sedaghat r, mirshafiey a (2015) new therapeutic approach by g2013 in experimental model of multiple sclerosis. acta neurologica belgica 115:259-66. |
|
Yang s, he h, ma qs, zhang y, zhu y, et al. (2015) experimental study of the protective effects of syvn1 against diabetic retinopathy. scientific reports 5. |
|
Choi ja, chung yr, byun hr, park h, koh jy, et al. (2017) the anti-als drug riluzole attenuates pericyte loss in the diabetic retinopathy of streptozotocin-treated mice. toxicology and applied pharmacology 315: 80-9. |
|
Wang y, yan h (2016) microrna-126 contributes to niaspan treatment induced vascular restoration after diabetic retinopathy. scientific reports 6. |
|
Kim m, kim y, lee sj (2015) comparison of aqueous concentrations of angiogenic and inflammatory cytokines based on optical coherence tomography patterns of diabetic macular edema. indian journal of ophthalmology 63: 312. |
|
Sieminski m, losy j, partinen m (2015). restless legs syndrome in multiple sclerosis. sleep medicine reviews 22:15-22. |
|
Tolentino ms, tolentino aj, tolentino mj (2016) current and investigational drugs for the treatment of diabetic retinopathy. expert opinion on investigational drugs 25: 1011-1022. |
|
Montesinos j, pascual m, pla a, maldonado c, rodrÃguez-arias m, et al. (2015) tlr4 elimination prevents synaptic and myelin alterations and long-term cognitive dysfunctions in adolescent mice with intermittent ethanol treatment. brain, behavior, and immunity 45:233-44. |
|
Agarwal d, gelman r, prospero ponce c, stevenson w, christoforidis jb (2015) the vitreomacular interface in diabetic retinopathy. journal of ophthalmology 2015. |
|
Chhablani j, bansal p, veritti d, sambhana s, sarao v, et al. (2016) dexamethasone implant in diabetic macular edema in real-life situations. eye 30: 426-430. |
|
Murugeswari p, shukla d, kim r, namperumalsamy p, stitt aw, et al. (2014) angiogenic potential of vitreous from proliferative diabetic retinopathy and eales' disease patients. plos one 9: e107551. |
|
Behl t, kaur i, goel h, kotwani a (2015) significance of the antiangiogenic mechanisms of thalidomide in the therapy of diabetic retinopathy. vascular pharmacology. |
|
Chakravarthy h, navitskaya s, o'reilly s, gallimore j, mize h, et al. (2016) role of acid sphingomyelinase in shifting the balance between proinflammatory and reparative bone marrow cells in diabetic retinopathy. stem cells. |
|
Ghasemi m, fatemi a (2014). pathologic role of glial nitric oxide in adult and pediatric neuroinflammatory diseases neuroscience & biobehavioral reviews 45:168-82. |
|
Van der giet m, henkel c, schuchardt m, tolle m (2015) anti-vegf drugs in eye diseases: local therapy with potential systemic effects. current pharmaceutical design 21: 3548-3556. |
|